119
Views
30
CrossRef citations to date
0
Altmetric
Review

Lycopene and prostate cancer: emerging evidence

, &
Pages 847-854 | Published online: 10 Jan 2014

References

  • World Cancer Report. Stewart BW, Kleihues P (Eds). IARC Press, Lyon, France (2003).
  • Jian L, Du CJ, Lee AH, Binns CW. Do dietary lycopene and other carotenoids protect against prostate cancer? Int. J. Cancer 113(6), 1010–1014 (2005).
  • Everson KM, McQueen CE. Lycopene for prevention and treatment of prostate cancer. Am. J. Health Syst. Pharm. 61(15), 1562–1566 (2004).
  • Barber NJ, Barber J. Lycopene and prostate cancer. Prostate Cancer Prostatic Dis. 5(1), 6–12 (2002).
  • Agarwal S, Rao AV. Tomato lycopene and its role in human health and chronic diseases. Can. Med. Assoc. J. 163(6), 739–744 (2000).
  • Giovannucci E. A review of epidemiological studies of tomatoes, lycopene, and prostate cancer. Exp. Biol. Med. 227(10), 852–859 (2002).
  • Pohar KS, Gong MC, Bahnson R, Miller EC, Clinton SK. Tomatoes, lycopene and prostate cancer: a clinician’s guide for counselling those at risk for prostate cancer. World J. Urol. 21(1), 9–14 (2003).
  • Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Intake of carotenoids and retinal in relation to risk of prostate cancer. J. Natl Cancer Inst. 87(23), 1767–1776 (1995).
  • Giovannucci E, Rimm EB, Liu Y, Stampfer MJ, Willet WC. A prospective study of tomato products, lycopene and prostate cancer risk. J. Natl Cancer Inst. 94(5), 391–398 (2002).
  • Schuurman AG, Goldbohm RA, Brants HAM, van den Brandt PA. A prospective cohort study on intake of retinol, vitamins C and E, and carotenoids and prostate cancer risk (Netherlands). Cancer Causes Control 13(6), 573–582 (2002).
  • Wu K, Erdman JW Jr, Schwartz SJ et al. Plasma and dietary carotenoids, and the risk of prostate cancer. A nested case-control study. Cancer Epidemiol. Biomarkers Prev. 13(2), 260–269 (2004).
  • Gann PH, Ma J, Giovannucci E et al. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res. 59(6), 1225–1230 (1999).
  • Huang HY, Alberg AJ, Norkus EP, Hoffman SC, Comstock GW, Helzlsouer KJ. Prospective study of anti-oxidant micronutrients in the blood and the risk of developing prostate cancer. Am. J. Epidemiol. 157(4), 335–344 (2003).
  • Bosetti C, Talamini R, Montella M et al. Retinol, carotenoids and the risk of prostate cancer: a case-control study from Italy. Int. J. Cancer 112(4), 689–692 (2004).
  • Vogt TM, Mayne ST, Graubard BI et al. Serum lycopene, other serum carotenoids, and risk of prostate cancer in US blacks and whites. Am. J. Epidemiol. 155(11), 1023–1032 (2002).
  • Sanderson M, Coker AL, Logan P, Zheng W, Fadden MK. Lifestyle and prostate cancer among older African–American and Caucasian men in South Carolina. Cancer Causes Control 15(7), 647–655 (2004).
  • Kolonel LN, Hankin JH, Whittemore AS. Vegetables, fruits, legumes and prostate cancer: a multiethnic case-control study. Cancer Epidemiol. Biomarkers Prev. 9(8), 795–804 (2000).
  • Cohen JH, Kristal AR, Stanford JL. Fruit and vegetable intakes and prostate cancer risk. J. Natl Cancer Inst. 92(1), 61–68 (2000).
  • Norrish AE, Jackson RT, Sharpe SJ, Skeaff CM. Prostate cancer and dietary carotenoids. Am. J. Epidemiol. 151(2), 119–123 (2000).
  • Lu QY, Hung JC, Heber D et al. Inverse associations between plasma lycopene and other carotenoids and prostate cancer. Cancer Epidemiol. Biomarkers Prev. 10(7), 749–756 (2001).
  • Kucuk O, Sarkar FH, Sakr W et al. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol. Biomarkers Prev. 10(8), 861–868 (2001).
  • Bowen P, Chen L, Stacewicz-Sapuntzakis M et al. Tomato sauce supplementation and prostate cancer: lycopene accumulation and modulation of biomarkers of carcinogenesis. Exp. Biol. Med. 227(10), 886–893 (2002).
  • Kim HS, Bowen P, Chen L et al. Effects of tomato sauce consumption on apoptotic cell death in prostate benign hyperplasia and carcinoma. Nutr. Cancer 47(1), 40–47 (2003).
  • Ansari MS, Gupta NP. A comparison of lycopene and orchidectomy vs. orchidectomy alone in the management of advanced prostate cancer. Br. J Urol. Int. 92(4), 375 (2003).
  • Ansari MS, Gupta NP. Lycopene: a novel drug therapy in hormone refractory metastatic prostate cancer. Urol. Oncol. 22(5) 415–420 (2004).
  • Boileau TWM, Liao Z, Kim S, Lemeshow S, Erdman JW Jr, Clinton SK. Prostate carcinogenesis in N-methyl-N-nitrosourea (NMU)-testosterone-treated rats fed tomato powder, lycopene, or energy-restricted diets. J. Natl Cancer Inst. 95(21), 1578–1586 (2003).
  • Venkateswaran V, Fleshner NE, Sugar LM, Klotz LH. Anti-oxidants block prostate cancer in lady transgenic mice. Cancer Res. 64(16), 5891–5896 (2004).
  • Guttenplan JB, Chen M, Kosinska W, Thompson S, Zhao Z, Cohen LA. Effects of a lycopene-rich diet on spontaneous and benzo[a]pyrene-induced mutagenesis in prostate, colon and lungs of the lacZ mouse. Cancer Lett. 164(1), 1–6 (2001).
  • Imaida K, Tamano S, Kato K et al. Lack of chemopreventive effects of lycopene and curcumin on experimental rat prostate. Carcinogenesis 22(3), 467–472 (2001).
  • Siler U, Barella L, Spitzer V et al. Lycopene and vitamin E interfere with autocrine/paracrine loops in the Dunning prostate cancer model. FASEB J. 18(9), 1019–1021 (2004).
  • Tang L, Jin T, Zeng X, Wang JS. Lycopene inhibits the growth of human androgen-independent prostate cancer cells in vitro and in BALB/c nude mice. J. Nutr. 135(2), 287–290 (2005).
  • Kim L, Rao AV, Rao LG. Effect of lycopene on prostate LNCaP cancer cells in culture. J. Med. Food 5(4), 181–187 (2002).
  • Kotake-Nara E, Kushiro M, Zhang H, Sugawara T, Miyashita K, Nagao A. Carotenoids affect proliferation of human prostate cancer cells. J. Nutr. 131(12), 3303–3306 (2001).
  • Obermuller-Jevic UC, Olano-Martin E, Corbacho AM et al. Lycopene inhibits the growth of normal human prostate epithelial cells in vitro. J. Nutr. 133(11), 3356–3360 (2003).
  • Mucci LA, Tamimi R, Lagiou P et al. Are dietary influences on the risk of prostate cancer mediated through the insulin-like growth factor system? Br. J Urol. Int. 87(9), 814–820 (2001).
  • Boyle P, Severi G, Giles GG. The epidemiology of prostate cancer. Urol. Clin. North Am. 30(2), 209–217 (2003).
  • Holden JM, Eldridge AL, Beecher GR et al. Carotenoid content of US foods: an update of the database. J. Food Comp. Anal. 12(3), 169–196 (1999).

Website

  • United States Department of Agriculture. USDA-NCC Carotenoid Database for US Foods. (1998). www.nal.usda.gov/fnic/foodcomp/Data/car98/car98.html (Accessed September 2005)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.